Back to top

Image: Bigstock

United Airlines to Boost China Service With Two More Flights

Read MoreHide Full Article

United Airlines Holdings (UAL - Free Report) is planning to increase service to Shanghai after the Chinese aviation authority permitted U.S. carriers to double flights to the nation. Upon China’s nod to this boosted service, the U.S. Department of Transportation has also allowed Chinese airlines to increase service to the United States from four weekly round-trips to eight.

United Airlines, carrying a Zacks Rank #4 (Sell), will increase service between San Francisco and Shanghai to four weekly flights from two, effective Sep 4. The carrier will utilize a Boeing 777-300ER aircraft to operate this route on Wednesdays, Fridays, Saturdays and Sundays. Tickets for this service are currently available for purchase on United Airlines’ official website.

Following a temporary suspension of service in February, United Airlines resumed the same between San Francisco and Shanghai's Pudong International Airport via Seoul's Incheon International Airport, in July. The airline operated five daily flights to Shanghai from its hubs in San Francisco, Los Angeles, Chicago and New York/Newark, prior to the coronavirus-related flights suspensions. Notably, the carrier has served mainland China for more than 30 years.


Delta Air Lines (DAL - Free Report) , which currently operates twice-a-week flights between Seattle and Shanghai-Pudong via Seoul-Incheon, might soon follow in United Airlines’ footsteps in boosting service to China. Delta carries the same Zacks Rank as United Airlines.

Key Picks

Some better-ranked stocks in the broader Transportation sector are Knight Swift Transportation Holdings (KNX - Free Report) and Werner Enterprises (WERN - Free Report) , both sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Shares of Knight Swift and Werner have rallied 23% each so far this year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in